Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit
- PMID: 10877570
Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit
Comment on
-
Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis.BMJ. 1999 Dec 11;319(7224):1529-33. doi: 10.1136/bmj.319.7224.1529. BMJ. 1999. PMID: 10591710 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical